Master Rollover Protocol for Continued Safety Assessment of Study Drug

Master Rollover Protocol for Continued Safety Assessment of Study Drug

This study is for patients who have participated in a previous study and who continue to receive benefit to have continued access to study drug and/or treatment.

Inclusion Criteria:

• To be eligible patients must be currently receiving benefit in a concluded Lilly study for a compound that has opened an addendum in the continued access protocol.

Exclusion Criteria:

• Patients must not be concurrently enrolled in any other type of medical research judged not to be scientifically or medically compatible with this study.